NICHOLAS INVESTMENT PARTNERS LP
Q2 2022 Form 13-F

RANCHO SANTA FE, CALIFORNIA
CIK 0001389574 · CRD 140159 · SEC-registered investment adviser
$1.1B Reported Value Total

NICHOLAS INVESTMENT PARTNERS, L.P. reports 42 total accounts under management (AUM). There are 41 discretionary accounts valued at $1,794,992,466, and 1 non-discretionary accounts valued at $2,964,248.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Firm Brochure (Part 2A) Client Relationship Summary (Form CRS)
Private funds (Form ADV)
4 funds · $445.8M gross asset value
Hedge Fund: $416.0M · Other: $29.8M
Source: Form ADV filed 2026-07-10
Reported value
$1.1B
Quarter over quarter
-19.3%
Holdings
149
Top-10 concentration
20.3%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Arthur Edward Nicholas
LIMITED PARTNER, AS SINGLE MEMBER OF AEN WY LLC
Catherine Charlotte Somhegyi Nicholas
MANAGING PARTNER, AS SINGLE MEMBER OF CCN WY LLC
Monika Garg
PORTFOLIO MANAGER
Q1 2022
Q3 2022
Go to latest

Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.

Loading 13F Metrics

Q2 2022 13F filing summary

Period of report June 30, 2022
Filed August 10, 2022
Form 13F-HR
Reported value $1.1B
Positions 149
Change in reported value -24.7%
New positions 33
Exited positions 51
Position turnover 42.0%
Top-10 concentration 20.3%

13F filings by quarter

Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
 175 $1.8B
Q1 2026 13F
Filed May 15, 2026
 178 $1.4B
Q4 2025 13F
Filed Feb 13, 2026
 177 $1.4B
Q3 2025 13F
Filed Nov 14, 2025
 181 $1.3B
Q2 2025 13F
Filed Aug 14, 2025
 183 $1.1B
Q1 2025 13F
Filed May 15, 2025
 166 $971.1M
Q4 2024 13F
Filed Feb 14, 2025
 183 $1.1B
Q3 2024 13F
Filed Nov 12, 2024
 184 $1.1B
Q2 2024 13F
Filed Aug 8, 2024
 157 $963.9M
Q1 2024 13F
Filed May 14, 2024
 168 $976.3M
Q4 2023 13F
Filed Feb 8, 2024
 163 $854.6M
Q3 2023 13F
Filed Nov 13, 2023
 150 $1.3B
Q2 2023 13F
Filed Aug 10, 2023
 159 $1.5B
Q1 2023 13F
Filed May 12, 2023
 156 $1.3B
Q4 2022 13F
Filed Feb 10, 2023
 150 $1.1B
Q3 2022 13F
Filed Nov 14, 2022
 152 $1.1B
Q2 2022 13F
Filed Aug 10, 2022
 149 $1.1B
Q1 2022 13F
Filed May 10, 2022
 165 $1.4B
Q4 2021 13F
Filed Feb 14, 2022
 162 $1.6B
Q3 2021 13F
Filed Nov 15, 2021
 157 $1.4B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2022

# Holding Reported value % of portfolio
1 ARGX ARGENX SE $30.3M 2.87%
2 ITCI INTRA-CELLULAR THERAPIES INC $24.8M 2.34%
3 EXE CHESAPEAKE ENERGY CORP $24.5M 2.31%
4 BHVN BIOHAVEN PHARMACTL HLDG CO L $20.0M 1.89%
5 PODD INSULET CORP $20.0M 1.89%
6 WSC WILLSCOT MOBIL MINI HLDNG CO $19.7M 1.87%
7 ESTA ESTABLISHMENT LABS HLDGS INC $19.6M 1.86%
8 SWAV SHOCKWAVE MED INC $19.2M 1.82%
9 HQY HEALTHEQUITY INC $18.6M 1.76%
10 RGEN REPLIGEN CORP $18.2M 1.72%
11 MPWR MONOLITHIC PWR SYS INC $17.6M 1.66%
12 VRTX VERTEX PHARMACEUTICALS INC $17.5M 1.65%
13 ESI ELEMENT SOLUTIONS INC $17.4M 1.65%
14 THS TREEHOUSE FOODS INC $17.4M 1.65%
15 HZNP HORIZON THERAPEUTICS PUB L $17.1M 1.62%
16 NARI INARI MED INC $16.7M 1.58%
17 XOM EXXON MOBIL CORP $16.5M 1.56%
18 RXDX PROMETHEUS BIOSCIENCES INC $15.0M 1.42%
19 KRYS KRYSTAL BIOTECH INC $15.0M 1.41%
20 LSCC LATTICE SEMICONDUCTOR CORP $14.1M 1.33%

Values as reported on the Q2 2022 Form 13F. Every position is in the holdings table below.

Loading Activities
Loading Sector Allocation
Crunching numbers
Loading Performance
Finding Potential New Buys
Building table
Loading SEC filing data
Loading Form 4 Filings
Loading 13D/G filings